Epidemiology of Merkel Carcinomas in the Bas-Rhin

University Hospital, Strasbourg, France150 enrolled

Overview

The aim of this work is to study demographic, clinical, management (diagnostic and therapeutic) and survival data concerning patients with Merkel's carcinoma in the Lower Rhine, thus obtaining the first French data.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Merkel Carcinoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \>18 years * Diagnosis of primary Merkel carcinoma (topographic code C44 morphological code 8247/3) * Diagnosis made between 1983 and 2011 * Patient residing in the Bas-Rhin at the date of diagnosis * Patient who has given his consent for the use of his data for research purposes Exclusion Criteria: \- Refusal to participate in research

Locations (1)

Service de Dermatologie

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Retrospective study of demographic, clinical, management (diagnostic and therapeutic) and survival data for patients with Merkel carcinoma in the Lower Rhine region

Time frame: The period from from January 1st, 1983 to December 31st, 2011 will be examined

Central Contacts

Dan LIPSKER, MD, PhD

CONTACT

33.3.88.11.61.79 dan.lipsker@chru-strasbourg.fr

Alice KIENY, MD

CONTACT

33.3.88.11.61.79 Alice.KIENY@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.